Improvement Keloid Scar in Child with Skin Type Fitzpatrick IV after Combination Therapy: A Case Report
DOI:
https://doi.org/10.52783/jns.v14.2192Keywords:
Child, keloids, Fitzpatrick IV skin type, skin color, CO₂ laser, triamcinolone acetonide, case report.Abstract
A keloid is a fibrous growth that forms when the skin's immune system reacts abnormally to trauma. Patients experience a diminished quality of life due to the cosmetic disfigurement and functional impairment caused by keloids. The recurrence rate is high, and keloid treatment is still challenging. The patient is a 16-year-old boy with a keloid history that dates back 2 years (Fitzpatrick IV). Thickened skin on the patient's trunk and left shoulder, together with itching, was the source of the patient's cosmetic complaints. This case was successfully treated by combination with one session of fractional carbon dioxide (CO2) laser and three sessions of triamcinolone acetonide injection. This is the first case report of a child (Fitzpatrick IV) who was successfully treated for a keloid utilizing a combined therapy of fractional CO2 laser and triamcinolone acetonide injection, with great cosmetic results that lasted one month after treatment. For patients with keloids on their face (Fitzpatrick IV-VI) and other skin types, we think this combined treatment strategy has a good chance of being safe and successful. This case demonstrates how the combination of fractional CO2 laser and intralesional steroid treatment results in a more efficient and successful therapy for keloid scars, as well as an improvement in patients’ quality of life.
Downloads
Metrics
References
E. Kraeva, D. Ho, and J. Jagdeo, “Successful Treatment of Keloid With Fractionated Carbon Dioxide (CO2) Laser and Laser-Assisted Drug Delivery of Triamcinolone Acetonide Ointment in an African-American Man.,” J. Drugs Dermatology JDD, vol. 16, no. 9, pp. 925–927, 2017.
K. Kassi et al., “Quality of life in black African patients with keloid scars,” Dermatology Reports, vol. 12, no. 2, p. 8312, 2020.
S. Alexander, B. S. Girisha, H. Sripathi, T. M. Noronha, and A. C. Alva, “Efficacy of fractional CO2 laser with intralesional steroid compared with intralesional steroid alone in the treatment of keloids and hypertrophic scars,” J. Cosmet. Dermatol., vol. 18, no. 6, pp. 1648–1656, 2019.
E. Bonnardeaux and C. McCuaig, “Surgical excision combined with fully ablative carbon dioxide laser therapy and triamcinolone injections as a potential treatment for keloids in children,” Pediatr. Dermatol., vol. 37, no. 1, pp. 137–141, 2020.
N. J. Thornton, B. A. Garcia, P. Hoyer, and M. G. Wilkerson, “Keloid scars: an updated review of combination therapies,” Cureus, vol. 13, no. 1, 2021.
Z. Zhuang, Y. Li, and X. Wei, “The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis,” Burns, vol. 47, no. 5, pp. 987–998, 2021.
A. D. Mamalis, H. Lev‐Tov, D. Nguyen, and J. R. Jagdeo, “Laser and light‐based treatment of Keloids–a review,” J. Eur. Acad. Dermatology Venereol., vol. 28, no. 6, pp. 689–699, 2014.
N. H. Sahib, M. K. Al-hattab, F. A. Fakhry, and I. J. Atiyah, “The role of fractional co2 laser in treatment of keloid and hypertrophic scar used alone and in combination with intralesional steroids,” Indian J. Forensic Med. Toxicol., vol. 14, no. 3, pp. 1545–1550, 2020.
M. Y. Listiawan, D. Murtiastutik, W. Sandhika, B. Rachmantyo, and P. H. Wardhani, “Comparison between fractional Co2 laser-triamcinolone injection combination therapy and triamcinolone injection monotherapy for keloid,” Dermatology Reports, vol. 11, no. 1s, pp. 39–40, 2019.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
